Web22 gen 2024 · 162 Background: We have conducted randomized three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel plus CF (DCF) versus radiation with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer, which is on-follow-up for primary analysis planned in 2024 (JCOG 1109). This study aimed to … http://www.jcog.jp/basic/org/group/jeog.html
食道がんグループ Japan Esophageal Oncology Group:JEOG - JCOG
Web14 ott 2024 · jcog1109研究表明,作为局部晚期食管鳞癌的新辅助治疗方案,dcf三药化疗相较于cf两药化疗显著改善了os,且毒性可控。 对于局部晚期食管鳞癌患者,新辅助治疗方案对生存至关重要,联合免疫治疗或许可以进一步改善食管鳞癌患者的生存 ,期待未来更多设计严谨的临床研究给出我们答案 。 Web22 gen 2024 · 162. Background: We have conducted randomized three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel plus CF (DCF) versus radiation with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer, which is on-follow-up for primary analysis planned in 2024 (JCOG 1109). This study aimed to … man city lich
Next study (JCOG1109): A three-arm randomized phase III study …
Web1) Histologically proven squamous cell carcinoma, adenosquamous carcinoma, or basaloid cell carcinoma. 2) All lesion located in the thoracic esophagus. 3) Clinical stage IB, II, III (excluding T4) based on the 7th UICC-TNM classification. 4) Aged 20 to 75 years old. 5) ECOG performance status of 0 or 1. WebJCOGで実施中の先進医療B試験⼀覧. 現在ご参加いただける登録中の試験は、下の左から2つめの条件「すべての登録状況」で「登録中」を選択してご覧ください。. 結果が公開された臨床試験では、試験一覧に表示されている「総括報告書」、「論文」の各 ... Web30 lug 2004 · DOI: 10.1109 DOI Values for: 10.1109; Index: Type: Timestamp: Data: 100: HS_ADMIN: 2005-01-19 17:37:54Z: handle=0.NA/10.1109; index=200; [create hdl,delete hdl,read ... koopa shell plush backpack